Amgen announces $1bn manufacturing expansion in Holly Springs
Biotechnology company Amgen is building a $1 billion drug substance manufacturing facility in Holly Springs, North Carolina, expanding its presence in the region with its second such facility. In tandem with its other investments, Amgen’s presence will add …